Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 8—August 2012
Dispatch

Klebsiella pneumoniae in Gastrointestinal Tract and Pyogenic Liver Abscess

Chang-Phone FungComments to Author , Yi-Tsung Lin, Jung-Chung Lin, Te-Li Chen, Kuo-Ming Yeh, Feng-Yee Chang, Han-Chuan Chuang, Hau-Shin Wu, Chih-Peng Tseng, and L. Kristopher Siu
Author affiliations: Taipei Veterans General Hospital, Taipei, Taiwan (C.P. Fung, Y.T. Lin, T.L. Chen, H.C. Chuang, H.S. Wu, C.P. Tseng); National Yang-Ming University, Taipei (C.P. Fung, Y.T. Lin, T.L. Chen, H.C. Chuang, H.S. Wu, C.P. Tseng); National Defense Medical Center, Taipei (J.C. Lin, K.M. Yeh, F. Y. Chang); National Health Research Institutes, Zhunan, Taiwan (L.K. Siu); and China Medical University, Taichung, Taiwan (L.K. Siu)

Main Article

Table 1

Clinical characteristics of 43 patients with Klebsiella pneumoniae liver abscess, Taiwan, January 2009–December 2010*

Characteristic No. (%) patients
 p value
Serotype K1/K2, n = 33 Non–K1/K2,† n = 10
Sex 0.89
M 19 (57.6) 6 (60.0)
F 14 (42.4) 4 (40.0)
Symptom/sign
Fever 33 (100.0) 10 (100.0)
Chills 20 (60.6) 4 (40.0) 0.25
RUQ pain/tenderness in abdomen 31 (94.0) 9 (90.0) 0.67
Nausea/vomiting 10 (30.3) 3 (30.0) 0.99
Leukocytosis, >103 cells/μL 32 (97.0) 10 (100.0) 1.00
Complication with distal metastasis 3 (9.1) 0 0.572
Endophthalmitis 1 (3.0) 0
Meningitis 1 (3.0) 0
Lung abscess 1 (3.0) 0
Underlying disease
Diabetes mellitus 20 (60.6) 5 (50.0) 0.55
Alcoholism 2 (6.0) 1 (10.0) 0.59
Malignancy 4 (12.1) 3 (30.0) 0.13
CVA 2 (6.0) 1(10.0) 0.59
Biliary tract diseases 8 (24.2) 5 (50.0) 0.12
Liver cirrhosis 2 (6.0) 0 1.00
COPD 1 (3.0) 0 1.00
Chronic renal insufficiency 7 (21.2) 2 (20.0) 0.93
HBsAg positive 2 (6.0) 0 1.00
Deaths 4 (12.1) 0 0.593

*Mean ages of patients were 67.3 for those infected with serotype K1/K2 and 68.6 y for those infected with non-K1/K2. RUQ, right upper quadrant; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary disease; HBsAg, hepatitis B surface antigen.
†Patients with serotypes K15 (1), K19 (3), K31 (1), K46 (1), K54 (2) and nontypeable (2).

Main Article

Page created: July 30, 2012
Page updated: July 30, 2012
Page reviewed: July 30, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external